These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17138490)

  • 1. Comparison of potentially hepatotoxic drugs among major US drug compendia.
    Guo JJ; Wigle PR; Lammers K; Vu O
    Res Social Adm Pharm; 2005 Sep; 1(3):460-79. PubMed ID: 17138490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of four drug interaction compendia.
    Vitry AI
    Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs.
    Chao SD; Maibach HI
    Am J Clin Dermatol; 2005; 6(2):105-11. PubMed ID: 15799682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Sakatis MZ; Reese MJ; Harrell AW; Taylor MA; Baines IA; Chen L; Bloomer JC; Yang EY; Ellens HM; Ambroso JL; Lovatt CA; Ayrton AD; Clarke SE
    Chem Res Toxicol; 2012 Oct; 25(10):2067-82. PubMed ID: 22931300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: The use of potentially hepatotoxic drugs in patients with liver disease.
    Gupta NK; Lewis JH
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1021-41. PubMed ID: 18671777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury.
    Chen M; Borlak J; Tong W
    Hepatology; 2013 Jul; 58(1):388-96. PubMed ID: 23258593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.
    Chitturi S; George J
    Semin Liver Dis; 2002; 22(2):169-83. PubMed ID: 12016548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatotoxic effects of drugs from some pharmacological groups].
    Kinzirskaia IuA; Bogush TA; Ostapchuk NV; Fisenko VP
    Klin Med (Mosk); 2003; 81(10):11-6. PubMed ID: 14664165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatotoxicity by Drugs: The Most Common Implicated Agents.
    Björnsson ES
    Int J Mol Sci; 2016 Feb; 17(2):224. PubMed ID: 26861310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance of severity ratings provided in four drug interaction compendia.
    Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Hansten PD; Van Bergen RC; Lipton RB
    J Am Pharm Assoc (2003); 2004; 44(2):136-41. PubMed ID: 15098847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology.
    Barbieri JS; St Claire K; Mostaghimi A; Albrecht J
    JAMA Dermatol; 2019 Mar; 155(3):315-320. PubMed ID: 30673082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compendia and anticancer therapy under Medicare.
    Tillman K; Burton B; Jacques LB; Phurrough SE
    Ann Intern Med; 2009 Mar; 150(5):348-50. PubMed ID: 19221368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rational use of potentially hepatotoxic medications in patients with underlying liver disease.
    Lewis JH
    Expert Opin Drug Saf; 2002 Jul; 1(2):159-72. PubMed ID: 12904150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity.
    He JH; Guo SY; Zhu F; Zhu JJ; Chen YX; Huang CJ; Gao JM; Dong QX; Xuan YX; Li CQ
    J Pharmacol Toxicol Methods; 2013; 67(1):25-32. PubMed ID: 23128142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New aspects of drug hepatotoxicity].
    Denjean P; Nouel O; N'Guyen JM; Beneton C; Allain H
    Ann Gastroenterol Hepatol (Paris); 1990 Dec; 26(7):293-8. PubMed ID: 2082807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of drug product information in four national compendia.
    Alloza JL; Lasagna L
    Clin Pharmacol Ther; 1983 Mar; 33(3):269-77. PubMed ID: 6825384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions involving antiepileptic drugs: assessment of the consistency among three drug compendia and FDA-approved labels.
    Ekstein D; Tirosh M; Eyal Y; Eyal S
    Epilepsy Behav; 2015 Mar; 44():218-24. PubMed ID: 25771206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.
    Uhl K; Kennedy DL; Kweder SL
    Drug Saf; 2002; 25(12):885-92. PubMed ID: 12241129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.